§ 360g–1. Agency documentation and review of significant decisions regarding devices
548 words·~2 min read·
/usc/title-21/section-360g-1A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary shall provide a substantive summary of the scientific and regulatory rationale for any significant decision of the Center for Devices and Radiological Health regarding submission or review of a report under section 360(k) of this title , a petition for classification under section 360c(f) of this title , an application under section 360e of this title , or an application for an exemption under section 360j(g) of this title , including documentation of significant controversies or differences of opinion and the resolution of such controversies or differences of opinion.
Upon request, the Secretary shall furnish such substantive summary to the person who is seeking to submit, or who has submitted, such report or application. The substantive summary required under this subsection shall include a brief statement regarding how the least burdensome requirements were considered and applied consistent with section 360c(i)(1)(D) of this title , section 360c(a)(3)(D) of this title , and section 360e(c)(5) of this title , as applicable. Any person may request a supervisory review of the significant decision described in subsection (a)(1).
Such review may be conducted at the next supervisory level or higher above the individual who made the significant decision. A person requesting a supervisory review under paragraph
(1)shall submit such request to the Secretary not later than 30 days after such decision and shall indicate in the request whether such person seeks an in-person meeting or a teleconference review. Except as provided in subparagraph (B), the Secretary shall schedule an in-person or teleconference review, if so requested, not later than 30 days after such request is made. The Secretary shall issue a decision to the person requesting a review under this subsection not later than 45 days after the request is made under paragraph (1), or, in the case of a person who requests an in-person meeting or teleconference, 30 days after such meeting or teleconference. Subparagraph
(A)shall not apply in cases that are referred to experts outside of the Food and Drug Administration. ( June 25, 1938, ch. 675, § 517A , as added Pub. L. 112–144, title VI, § 603 , July 9, 2012 , 126 Stat. 1051 ; amended Pub. L. 114–255, div. A, title III , §§ 3051(b), 3058(c), Dec. 13, 2016 , 130 Stat. 1124 , 1129; Pub. L. 117–328, div. FF, title III, § 3308(b)(3) , Dec. 29, 2022 , 136 Stat. 5836 .)
Connections8 cite this · traces to 2
Cited by 8 sections
Traces to 2 documents
4 references not yet in our index
- Pub. L. 112-144
- 126 Stat. 1051
- 130 Stat. 1124
- 136 Stat. 5836
Citation graph
cites case law
§ 360g–1
Agency documentation and review of significant decisions regarding devices
Fed. Reg.×6
Stat. Comp.×2
Pub. L.Pub. L. 112-144
Stat.126 Stat. 1051
Stat.130 Stat. 1124
Stat.136 Stat. 5836
Cites 6Cited by 8 across 2 sources